-
Protalix's UPLYSO Granted Regulatory Approval In Mexico And Chile For Gaucher Disease
4/29/2013
|
-
Protalix BioTherapeutics Treats First Gaucher Patient In Phase I Study With PRX-112
4/2/2013
|
|
|
-
Pfizer, Protalix BioTherapeutics Say UPLYSO Approved In Brazil By ANVISA For Treatment Of Gaucher Disease
3/18/2013
|
|
|
|
|
|
|
-
Protalix BioTherapeutics Announces First Patient Treated In Phase I/II Study Of Fabry Patients With PRX-102
12/10/2012
|
|
|
-
Protalix BioTherapeutics Signs Clinical Development Agreement With Pfizer For ELELYSO
12/6/2012
|